Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thailand Plans To Produce Own Generics Of Major Drugs

This article was originally published in PharmAsia News

Executive Summary

Thailand's Government Pharmaceutical Organization is building a $22.2 million plant to manufacture its own versions of major drugs it feels are too expensive. The plant is expected to be completed within six months and able to produce its first drugs early next year, at a rate of three billion tablets a year. The GPO currently imports generics from other countries to replace branded drugs it has declared subject to compulsory license. With its own plant, the agency hopes to save money on even the imports and speed patient access to the medicines. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067904

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel